SHANMUGA.BO · BSE
SHANMUGA HOSPITAL LIMITED
₹46
-3.77% (-₹1.8)
Prev. close
₹47.8
Volume
2,000
As of
24 Sept 2026
Price history
No analyst calls on this stock in the last 90 days yet.
Explore by date range →Analyst opinions
Fundamentals
About SHANMUGA HOSPITAL LIMITED
Shanmuga Hospital Limited operates a multispecialty hospital in Tamil Nadu. The company offers inpatient and outpatient care across various advanced robotic surgery, oncology, surgical and medical oncology, radiation oncology, general surgery and gastroenterology, orthopedics and rheumatology, cardiology, general medicine and geriatrics, pediatrics and neonatology, obstetrics and gynecology, neurology, nephrology, urology, psychiatry, radiology, otolaryngology, diabetology, dentistry, physical medicine and rehabilitation, hematology, and pulmonology. It also provides services, such as equipment, facilities, insurance, dialysis care, and rooms. Shanmuga Hospital Limited was founded in 1981 and is based in Salem, India.
Details
Sector
Healthcare
Industry
Medical Care Facilities
CEO
Dr. Prabu Sankar Panneerselvam
Headquarters
Salem
Employees
254
Website
shanmugahospital.comExchange
View on BSE ↗Key stats
Market cap
₹65.07 Cr
P/E ratio (TTM)
15.4
EPS (TTM)
₹3.11
Beta (1Y · daily vs NIFTY 50)
0.61
Shares float
34.70 L
EPS · quarter ended Jun 2026
₹0.72
Financial Performance
01 · Financials
FY23 growth needs FY22 filings, which the data source doesn't provide.
02 · Earnings Per Share (EPS)
04 · Operating Efficiency (Growth Rates)
Balance-sheet-based · pre-FY23 not filed in verifiable form
05 · Capital Structure & Asset Utilization
Pre-FY23 not filed in verifiable form
Asset turnover needs a prior year of assets — omitted for the earliest available year.
06 · Asset Base Composition
Pre-FY23 not filed in verifiable form
07 · Debt Level & Coverage
Pre-FY23 not filed in verifiable form
08 · Profit & Loss
Annual
| Line item | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| ₹39.34 Cr | ₹43.04 Cr | ₹47.85 Cr | ₹47.44 Cr | |
| EBITDA | ₹7.43 Cr | ₹8.85 Cr | ₹8.47 Cr | ₹8.91 Cr |
| ₹4.76 Cr | ₹5.25 Cr | ₹4.21 Cr | ₹4.21 Cr | |
| Diluted EPS | ₹3.5 | ₹3.86 | ₹4.03 | ₹3.09 |
Total expenses (as filed), Employee benefit expense, Other expenses have filed figures for only some of the years shown — the missing years are left blank rather than estimated.
09 · Balance Sheet
Annual
| Line item | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| ₹23.05 Cr | ₹33.92 Cr | ₹52.78 Cr | ₹53.06 Cr | |
| ₹7.65 Cr | ₹9.02 Cr | ₹7.61 Cr | ₹6.74 Cr | |
| Stockholders' equity | ₹11.82 Cr | ₹17.13 Cr | ₹39.70 Cr | ₹42.50 Cr |
Annual only — the data source doesn’t publish quarterly balance-sheet detail for most NSE-listed companies.
10 · Cash Flow Statement
Annual
| Line item | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| ₹2.95 Cr | ₹9.58 Cr | ₹-1.57 Cr | ₹12.31 Cr | |
| Investing cash flow | ₹-8.31 Cr | ₹-11.59 Cr | ₹-4.34 Cr | ₹-20.33 Cr |
| Financing cash flow | ₹7.37 Cr | ₹89.85 L | ₹16.39 Cr | ₹-2.65 Cr |
| Capital expenditure | ₹-8.27 Cr | ₹-11.51 Cr | ₹-4.40 Cr | ₹-20.47 Cr |
| End cash position | ₹3.21 Cr | ₹2.10 Cr | ₹12.59 Cr | ₹1.93 Cr |
Annual only — the data source has no quarterly cash-flow-statement coverage.
12 · Peer Comparison
Healthcare
| Company | ||||||||
|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹4.47 L Cr | ₹1,849.9 | 37.0 | 5.35 | 13.7% | 0.06 | +11.9% | +13.7% |
| Divi's Laboratories Limited | ₹2.55 L Cr | ₹9,602 | 87.2 | 15.24 | 15.3% | 0.00 | +12.3% | +60.5% |
| Torrent Pharmaceuticals Limited | ₹1.90 L Cr | ₹4,928.5 | 79.5 | 22.60 | 25.8% | 1.79 | +21.5% | +36.3% |
| Apollo Hospitals Enterprise Limited | ₹1.30 L Cr | ₹8,888.5 | 61.0 | 13.75 | 20.5% | 0.90 | +15.7% | +16.3% |
| Lenskart Solutions Limited | ₹1.19 L Cr | ₹676 | 180.7 | 13.61 | 5.6% | 0.35 | +35.4% | — |
| Zydus Lifesciences Limited | ₹1.17 L Cr | ₹1,180.3 | 26.1 | 4.31 | 18.6% | 0.46 | +18.4% | +13.9% |
| Cipla Limited | ₹1.12 L Cr | ₹1,399 | 33.2 | 3.24 | 11.3% | 0.02 | +2.1% | -9.0% |
| Laurus Labs Limited | ₹1.10 L Cr | ₹2,026.2 | 100.9 | 20.84 | 16.8% | 0.48 | +22.0% | +122.7% |
| Max Healthcare Institute Limited | ₹1.03 L Cr | ₹1,046 | 71.1 | 9.60 | 13.4% | 0.32 | +19.0% | -7.7% |
| Mankind Pharma Limited | ₹1.02 L Cr | ₹2,500 | 49.0 | 6.25 | 11.7% | 0.39 | +17.0% | -1.2% |
| Dr. Reddy's Laboratories Limited | ₹1.01 L Cr | ₹1,200.4 | 30.5 | 2.68 | 11.4% | 0.21 | +3.2% | -7.5% |
| SHANMUGA HOSPITAL LIMITED | ₹65.07 Cr | ₹47.8 | 15.4 | 1.53 | 9.9% | 0.16 | -0.9% | +3.2% |
Ranked by market cap within Healthcare, same metrics as the Fundamentals screener. Click a column to sort.
Documents
Annual reports
Official documents linked from their sources — offer documents as filed with SEBI (sebi.gov.in), annual reports and earnings-call transcripts as published on BSE (bseindia.com) and NSE (nseindia.com). Links open the source's own hosting; nothing is re-hosted here.